MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Profile and Predictors of Depression in Parkinson’s Disease Patients attending the Neurology Clinic at the University College Hospital, Ibadan, Nigeria.

A. Fagbemi, F. Taiwo, T. Sodimu (East Midlands, United Kingdom)

Meeting: 2025 International Congress

Keywords: Depression, Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: My aim is to investigate the frequency, profile, and predictors of depression in PD patients compared to age- and gender-matched controls using the Hamilton Rating Scale for Depression (HAM-D).

Background: Parkinson’s disease (PD) is a neurodegenerative disorder primarily characterized by motor symptoms such as tremors, bradykinesia, and rigidity, as well as non-motor symptoms, including depression. Depressive symptoms in PD are often under-recognized, under-diagnosed, and, even when identified, frequently undertreated.

Method: 130 patients with a clinical diagnosis of PD at the University College Hospital in Ibadan had the Hamilton Depression Scale and Montreal Cognitive Assessment administered to them. It employed a comparative cross-sectional design with a consecutive sampling technique to examine Parkinson’s disease patients and matched healthy controls. A structured questionnaire interview and a neurological examination, including the Hoehn and Yahr stage of illness scale and the motor section of the Unified Parkinson’s Disease Rating Scale, were performed. An equal number of age- and gender-matched controls were recruited for the study.

Results: Of the 130 PD patients, depression was found in 71.5% of the patients. Based on their Hamilton Depression Scale, 53.1% had mild depression, 16.9% had moderate depression, and 1.5% had severe depression. As the Hoen and Yahr staging of PD severity increased from Stage 1 (40 mild (30.8%), 5 moderate depression(3.8%)) to Stage 2 (22 mild(16.9%), 8 moderate(6.2%)), Stage 3 (6 mild(4.6%), 9 moderate(6.9%), 1 severe(0.8%)), and Stage 4/5(2 severe(1.5%)),the severity of depression worsened, with a progressive shift from mild to moderate and severe depression.

Conclusion: Patients with PD had a higher frequency of depression compared to their healthy counterparts. Longer duration of PD, higher scores on the Unified Parkinson’s Disease Rating Scale (UDPRS), and motor phenotype (PIGD) were significantly associated with depression. Additionally, older age, lower BMI, and presence of non-motor symptoms (cognitive impairment, autonomic dysfunction, sleep disturbances) also correlated with increased depression severity.

Hamilton Depression Categorization

Hamilton Depression Categorization

HAM-D Comparison with Hoen-Yahr stage.

HAM-D Comparison with Hoen-Yahr stage.

Cross Tabulation of Case HAM-D and Motor Phenotype

Cross Tabulation of Case HAM-D and Motor Phenotype

To cite this abstract in AMA style:

A. Fagbemi, F. Taiwo, T. Sodimu. Profile and Predictors of Depression in Parkinson’s Disease Patients attending the Neurology Clinic at the University College Hospital, Ibadan, Nigeria. [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/profile-and-predictors-of-depression-in-parkinsons-disease-patients-attending-the-neurology-clinic-at-the-university-college-hospital-ibadan-nigeria/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/profile-and-predictors-of-depression-in-parkinsons-disease-patients-attending-the-neurology-clinic-at-the-university-college-hospital-ibadan-nigeria/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley